Nutrien Ltd.
NYSE:NTRAgricultural Inputs
-$1.56 today
- Market cap
- $31.25B
- Beta
- 1.06
- P/E (TTM)
- 12.6
- EPS (TTM)
- $4.96
- Dividend yield
- 3.48%
Volume 1.80M
Average 3.18M
NTR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Nutrien Ltd.NYSE: NTR
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA dips below year-ago levels
Q2 FY2026 EBITDA of $2.38B fell 0.6% year over year, behind the +26.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 146.5% from the prior quarter. Over 3 fiscal years it compounded at -21.6% a year.
Context
- EBITDA amounted to 22.9% of revenue in FY2025, up 6.6 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 11 analysts of $6.24B (+1.5%) for the fiscal year ending Dec 2026, a slowdown from the +45.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $2.38B+146.5% QoQ
- Last fiscal yearDec 2025
- $6.15B+45.9% YoY
- LTMJun 2026
- $6.3B+26.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.6% | -4.8% | -4.1 pp |
| 1 year | +45.9% | +1.5% | -44.4 pp |
| 3-year CAGR | -21.6% | +0.2% | +21.8 pp |
| 5-year CAGR | +0.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 6.15B USD
- Year-over-year change
- +45.9%
- 4-year CAGR
- -1.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.15B | +45.9% |
| FY2024 | 2024-12-31 | 4.21B | -13.8% |
| FY2023 | 2023-12-31 | 4.89B | -61.8% |
| FY2022 | 2022-12-31 | 12.78B | +94.2% |
| FY2021 | 2021-12-31 | 6.58B | — |
EBITDA vs competitors
How NTR compares with its peers on the latest reported figures
- NTR's LTM Jun 2026 EBITDA of $6.3B is the highest of the 4 companies compared; the peer median is $1.55B.
- Its year-over-year change of +26.2% is the 2nd highest of 4, against a peer median of +8.1%.
- EBITDA amounts to 22.3% of revenue for NTR, versus a peer median of 20.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.3B | +26.2% | -21.6% | 22.3% | |
| LTM Jun 2026 | $4.16B | +42.4% | -19.4% | 53.8% | |
| LTM Sep 2026 | $1.55B | +8.1% | -30.5% | 20.0% | |
| LTM Sep 2026 | $990.1M | -67.0% | -24.4% | 8.6% | |
| Peer median (excluding NTR) | $1.55B | +8.1% | -24.4% | 20.0% | |
Competitors are the stored peer set for NTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 27.71B | 37.88B | 29.06B | 25.97B | 26.89B |
| Cost of Revenue | 18.3B | 22.46B | 20.58B | 18.44B | 18.54B |
| Gross Profit | 9.41B | 15.42B | 8.47B | 7.53B | 8.35B |
| Gross Margin | 34.0% | 40.7% | 29.2% | 29.0% | 31.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.82B | 4.09B | 4.06B | 4.17B | 4.1B |
| Operating Expenses | 4.63B | 4.62B | 4.61B | 4.58B | 4.48B |
| Depreciation & Amortization | 1.95B | 2.01B | 2.17B | 2.34B | 2.37B |
| EBITDA | 6.58B | 12.78B | 4.89B | 4.21B | 6.15B |
| EBITDA Margin | 23.8% | 33.7% | 16.8% | 16.2% | 22.9% |
| Operating Income | 4.78B | 10.81B | 3.86B | 2.95B | 3.87B |
| Operating Margin | 17.3% | 28.5% | 13.3% | 11.4% | 14.4% |
| Interest Income | 7.93M | 24.01M | 35.64M | 26.66M | 51M |
| Interest Expense | 474.79M | 529.17M | 804.49M | 660.68M | 729M |
| Other Income / Expenses | (613M) | (563M) | (1.91B) | (1.82B) | (820M) |
| Income Before Tax | 4.17B | 10.25B | 1.95B | 1.14B | 3.05B |
| Pre-Tax Margin | 15.0% | 27.0% | 6.7% | 4.4% | 11.3% |
| Income Tax Expense | 989M | 2.56B | 670M | 436M | 752M |
| Net Income | 3.15B | 7.66B | 1.26B | 674M | 2.27B |
| Net Margin | 11.4% | 20.2% | 4.3% | 2.6% | 8.4% |
| EPS (Basic) | 5.49 | 13.66 | 2.53 | 1.36 | 4.74 |
| EPS (Diluted) | 5.47 | 13.62 | 2.53 | 1.36 | 4.74 |
| Weighted Avg Shares | 569.66M | 538.48M | 496.38M | 494.37M | 486.34M |
| Weighted Avg Shares (Diluted) | 571.29M | 540.01M | 496.99M | 494.37M | 486.52M |
Nutrien Ltd.
NYSE:NTR
Intrinsic Alpha fair value
Locked
Current Price
$65.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.